Related references
Note: Only part of the references are listed.Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
Esther E. Creemers et al.
CARDIOVASCULAR RESEARCH (2011)
Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation
Thomas P. Cappola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Peripartum Cardiomyopathy as a Part of Familial Dilated Cardiomyopathy
Karin Y. van Spaendonck-Zwarts et al.
CIRCULATION (2010)
MicroRNAs Add a New Dimension to Cardiovascular Disease
Eric M. Small et al.
CIRCULATION (2010)
Deep mRNA Sequencing for In Vivo Functional Analysis of Cardiac Transcriptional Regulators Application to Gαq
Scot J. Matkovich et al.
CIRCULATION RESEARCH (2010)
MiR423-5p As a Circulating Biomarker for Heart Failure
Anke J. Tijsen et al.
CIRCULATION RESEARCH (2010)
Heart Failure-Associated Changes in RNA Splicing of Sarcomere Genes
Sek Won Kong et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Association of Genome-Wide Variation With the Risk of Incident Heart Failure in Adults of European and African Ancestry A Prospective Meta-Analysis From the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium
Nicholas L. Smith et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Genomic Variation Associated With Mortality Among Adults of European and African Ancestry With Heart Failure The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium
Alanna C. Morrison et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
Jasper Jan Brugts et al.
EUROPEAN HEART JOURNAL (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
ChIP-Seq identification of weakly conserved heart enhancers
Matthew J. Blow et al.
NATURE GENETICS (2010)
Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome
Sarah B. Ng et al.
NATURE GENETICS (2010)
Differential DNA Methylation Correlates with Differential Expression of Angiogenic Factors in Human Heart Failure
Mehregan Movassagh et al.
PLOS ONE (2010)
Variation in Transcription Factor Binding Among Humans
Maya Kasowski et al.
SCIENCE (2010)
Drug-Sensitized Zebrafish Screen Identifies Multiple Genes, Including GINS3, as Regulators of Myocardial Repolarization
David J. Milan et al.
CIRCULATION (2009)
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Sharon Ann Hunt et al.
CIRCULATION (2009)
Genetic Variants Associated With Cardiac Structure and Function A Meta-analysis and Replication of Genome-wide Association Data
Ramachandran S. Vasan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline
Ray E. Hershberger et al.
JOURNAL OF CARDIAC FAILURE (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Pharmacogenetic profiling in the treatment of heart disease
Gerald W. Dorn
TRANSLATIONAL RESEARCH (2009)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
A genetic framework for improving arrhythmia therapy
Bjorn C. Knollmann et al.
NATURE (2008)
Tackling heart failure in the twenty-first century
James O. Mudd et al.
NATURE (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy
Blanche Schroen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
Control of stress-dependent cardiac growth and gene expression by a microRNA
Eva van Rooij et al.
SCIENCE (2007)
Epigenetic variation and inheritance in mammals
Vardhman K. Rakyan et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2006)
Differential gene expression profiling in genetic and multifactorial cardiovascular diseases
Luisa Nanni et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
Roland R. van Kimmenade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Gγ1
Peng Yi et al.
SCIENCE (2006)
Association of parental heart failure with risk of heart failure in offspring
Douglas S. Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR
Esther E. Creemers et al.
MOLECULAR CELL (2006)
A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep
Alex Clop et al.
NATURE GENETICS (2006)
Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure
BM Mayosi et al.
HEART (2006)
Long-range control of gene expression: Emerging mechanisms and disruption in disease
DA Kleinjan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Thrombospondin-2 is essential for myocardial matrix integrity - Increased expression identifies failure-prone cardiac hypertrophy
B Schroen et al.
CIRCULATION RESEARCH (2004)
Titin isoform switch in ischemic human heart disease
C Neagoe et al.
CIRCULATION (2002)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure
JJ Hwang et al.
PHYSIOLOGICAL GENOMICS (2002)
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
BD Lowes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
